Biliary Tract Cancers
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) (NCT03797326) | Merck Sharp & Dohme LLC | 2019-02-12 |
Track Biliary Tract Cancers automatically
Every clearance here is in the API, with alerts when new ones post.